Pregnancy Diagnosis in Cattle: Methods and Accuracy

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Transrectal ultrasonography offers the earliest reliable pregnancy diagnosis in cattle, detecting the embryonic vesicle from Day 26-28 and fetal heartbeat from Day 26, enabling prompt rebreeding of open cows.
• Transrectal palpation is a cost-effective method, becoming reliable from Day 30-35 for amniotic vesicle detection and Day 35-40 for membrane slip, but lacks fetal viability assessment and is operator-skill dependent.
• Pregnancy-associated glycoprotein (PAG) blood tests provide a laboratory-based diagnosis from Day 24-28, detecting placental glycoproteins, but do not assess fetal viability and require laboratory processing or specific cow-side kits.
• Early embryonic mortality is a significant complication, with positive PAG tests at Day 28 correlating with pregnancy maintenance probability, necessitating rechecking high-risk animals to confirm term pregnancy.
• Method selection hinges on gestational age, available equipment, herd goals, and the need to assess fetal viability or detect twins, with ultrasound being superior for these latter criteria.
• Accurate record-keeping of diagnosis date, method, gestational age, and specific findings is crucial for herd-level reproductive performance analysis and identifying issues like late embryonic mortality.

Accurate pregnancy diagnosis is a central element of reproductive management in both dairy and beef herds. The economic value of an early, reliable diagnosis lies in the identification of open cows, allowing for prompt rebreeding or treatment and reducing the calving interval. This article provides a comparative review of the principal methods available to the bovine practitioner: transrectal palpation, transrectal ultrasonography, and laboratory assays for pregnancy-associated glycoproteins (PAGs). Each method is examined for its physiological basis, optimal timing, diagnostic accuracy, and practical limitations.

The intended reader is the practicing veterinarian who must select a diagnostic approach based on herd goals, available equipment, and the stage of gestation. The clinical questions addressed include when each method becomes diagnostically reliable, how to interpret equivocal results, and which method best serves early embryonic mortality monitoring. The physiological events that underpin each test are reviewed first, as they determine the window of validity for every diagnostic modality.

At a Glance

Physiology of Early Gestation and Diagnostic Targets

The selection of a pregnancy test depends on which product of conception is being detected and when it appears. The maternal recognition of pregnancy in cattle occurs around Day 16 to 17, when the elongating conceptus secretes interferon-tau to maintain the corpus luteum. The corpus luteum itself is not a pregnancy-specific structure, so its presence alone cannot confirm gestation. The first pregnancy-specific signals are the embryonic membranes and, later, the placental glycoproteins that enter the maternal circulation.

The bovine placenta begins forming as the trophoblast differentiates, and binucleate cells migrate and fuse with maternal uterine epithelium. These binucleate cells are the source of the pregnancy-associated glycoproteins, a large family of proteins structurally related to pepsin. The expression of individual PAG genes varies over the course of gestation. Some PAGs are expressed weakly at Day 25 but become abundant later, while others are present from Day 25 onward, providing the molecular basis for early blood-based diagnosis Green et al., pregnancy-associated bovine and ovine glycoprotein expression patterns. The first significant rise in circulating PAG concentration after insemination occurs around Day 24, which sets the lower boundary for reliable blood testing Pohler et al., bovine pregnancy-associated glycoproteins and late embryonic mortality.

The embryonic vesicle is palpable by transrectal palpation once it has grown sufficiently to be detected through the uterine wall. The chorioallantoic membrane slips between the examiner's fingers, and the amniotic vesicle becomes identifiable. These structures develop progressively, which explains why palpation before Day 35 yields unacceptably high false-negative rates. Ultrasonography detects the embryonic vesicle and its fluid earlier, and the fetal heartbeat provides a definitive viability signal.

Transrectal Palpation

Transrectal palpation remains a valid and economical method, particularly in settings where ultrasound is unavailable. The examiner identifies the uterine horn for asymmetry, the presence of an amniotic vesicle, and the characteriztic slip of the chorioallantoic membrane between the thumb and forefinger. Membrane slip is typically detectable from Day 30 to 35, and the amniotic vesicle from Day 35 onward. Placentomes become palpable from approximately Day 70 to 75.

The accuracy of palpation improves with gestational age and operator experience. Before Day 35, the diagnosis is unreliable because the vesicle is too small to detect consistently. Between Day 35 and 45, experienced examiners achieve high accuracy, but errors occur from confusing a pyometra or a regressing corpus luteum with pregnancy. Palpation cannot assess fetal viability after embryonic death, as the membranes may persist for days or weeks. The method also carries a small risk of iatrogenic fetal loss if the examiner is overly vigorous, particularly before Day 42.

Transrectal Ultrasonography

Transrectal ultrasonography with a 5 to 7.5 MHz linear probe has become the standard for early diagnosis in many practices. The embryonic vesicle is visible as a discrete anechoic structure within the uterine lumen from Day 26 to 28. The embryo proper and its heartbeat are detectable from approximately Day 26, and the heartbeat confirms viability. By Day 30, the embryo is consistently identified, and by Day 35, the fetal heartbeat is reliably visualized in nearly all pregnancies.

Ultrasound offers two advantages over palpation. First, it detects pregnancy earlier, enabling a nonpregnant diagnosis within the same synchronization protocol. This allows resynchronization and rebreeding within days of a negative diagnosis, a strategy that improves overall pregnancy rates in timed artificial insemination programs Thatcher et al., strategies for improving fertility in the modern dairy cow. Second, ultrasound distinguishes a viable pregnancy from embryonic loss. A cow diagnosed pregnant at Day 28 with a visible heartbeat can be rechecked if subsequent embryonic mortality is suspected.

The limitations of ultrasound include the cost of equipment, the need for training, and the difficulty of imaging in cows with excessive pelvic fat or poor rectal relaxation. Fetal sexing is possible from Day 55 to 60 but requires additional skill and is not part of routine pregnancy diagnosis.

Blood-Based Pregnancy Diagnosis

Measurement of pregnancy-associated glycoproteins (PAGs) in maternal circulation offers a laboratory-based alternative to imaging methods. The PAG family comprises multiple gene products expressed by the trophectoderm, with distinct spatial and temporal expression patterns across gestation. Some PAGs appear as early as Day 25, while others, including the widely assayed boPAG-1, are expressed weakly at that stage but increase substantially as pregnancy advances. This heterogeneity has practical consequences for assay performance, because commercial tests vary in which PAG isoforms they detect.

The first significant rise in serum PAG concentration occurs around Day 24 after insemination in postpartum Nelore beef cows, and pregnancy diagnosis is commonly performed between Days 28 and 30. At this time point, circulating PAG concentration also carries prognostic information. Cows that maintain pregnancy to Day 100 have significantly higher Day 28 PAG concentrations than cows that undergo late embryonic mortality, and the probability of pregnancy maintenance increases as maternal PAG concentration rises. A receiver operating characteriztic analysis can identify a threshold concentration that optimizes sensitivity and specificity for predicting pregnancy maintenance, although the optimal cut point varies by assay and population.

Blood-based diagnosis offers several practical advantages. It requires no transrectal manipulation, which is relevant for cows with temperament issues, vaginal or cervical pathology, or recent embryo transfer where uterine handling is undesirable. Samples can be collected by the herd veterinarian or farm staff and submitted to a diagnostic laboratory, which suits large synchronised breeding programs where throughput is a priority. The principal limitation is the absence of immediate results, although cow-side PAG tests are available in some regions and reduce turnaround time to minutes.

Interpretation requires attention to timing. Assays that detect early-expressed PAG isoforms can identify pregnancy from Day 24, but testing before this point risks false negatives because PAG concentrations may not yet exceed the assay threshold. Late embryonic mortality after a positive test produces a false positive relative to a later examination, and the magnitude of the Day 28 PAG concentration can help predict which pregnancies are at risk. For this reason, a positive blood test at Day 28 should be interpreted as evidence of a viable conceptus at the time of sampling, not as a guarantee of term pregnancy.

Method Comparison and Selection

The choice of pregnancy diagnosis method depends on gestational age, available equipment, herd size, and the management decision that the diagnosis will inform. The table below summarizes the principal methods and their practical characteriztics.

The early pregnancy diagnosis literature emphasizes that no single method satisfies all requirements for sensitivity, specificity, speed, and ease of performance. The ideal method would combine the immediacy of ultrasound with the objectivity of a laboratory assay, but such a method does not currently exist. In practice, the correct choice balances the cost of a false diagnosis against the cost of delayed diagnosis.

For timed artificial insemination programs, resynchronisation of nonpregnant cows combined with ultrasound examination allows a second timed insemination within three days of a nonpregnant diagnosis. This workflow favours ultrasound because it provides immediate results that feed directly into the breeding schedule. Blood testing introduces a delay that may push the second insemination outside the optimal resynchronisation window unless samples are processed rapidly.

For herds without ultrasound capability, transrectal palpation remains a serviceable method from Day 35 onward. The technique provides additional information about uterine tone, cervical closure, and ovarian structures that a blood test cannot supply. However, palpation before Day 35 carries a meaningful risk of false negative diagnosis, and the examiner must be prepared to recheck equivocal cases.

Diagnostic Sequence and Decision Points

A structured approach to pregnancy diagnosis reduces errors and ensures that the method matches the clinical question. The sequence begins with confirmation of the breeding date or timed insemination protocol, because gestational age determines which methods are valid. For animals bred at observed estrus, the date is usually reliable. For animals bred following synchronisation protocols that include GnRH-induced ovulation, the timing of ovulation may vary by up to a day, which is rarely clinically significant for diagnosis after Day 28.

The first decision point is whether the examination occurs before or after Day 28. Before Day 28, transrectal ultrasonography can detect the embryonic vesicle, but the risk of embryonic loss in the subsequent two weeks is substantial, and a positive diagnosis may not reflect the final pregnancy outcome. Blood PAG testing before Day 24 is not recommended because concentrations may not have risen above the assay threshold. After Day 28, all three principal methods become viable, and the choice shifts to practical considerations.

The second decision point is whether the diagnosis must distinguish viable from nonviable pregnancy. Ultrasonography with fetal heartbeat detection provides this distinction directly. PAG concentration provides a probabilistic assessment, with higher concentrations associated with greater likelihood of maintenance to Day 100. Palpation provides indirect evidence of viability through uterine tone and fluid presence, but cannot confirm a heartbeat.

The third decision point is whether the examination must detect twins or estimate fetal age. Transrectal ultrasonography is the only method among those discussed that reliably identifies twin pregnancies and provides fetal measurements for gestational aging. Herds with high twinning rates, particularly dairy herds with a history of multiple ovulation, benefit from ultrasound examination even when a blood test would provide a simpler pregnancy diagnosis.

Documentation and Herd-Level Interpretation

Pregnancy diagnosis records should include the animal identification, breeding date, examination date, method used, and the specific findings that support the diagnosis. For ultrasound examinations, the presence of a fetal heartbeat, the number of fetuses, and any abnormal findings such as fetal fluid accumulation or uterine pathology should be recorded. For blood tests, the laboratory report should include the PAG concentration and the assay's reported sensitivity at the gestational age tested.

Herd-level interpretation of pregnancy diagnosis data supports reproductive management beyond the individual animal. The proportion of animals diagnosed pregnant at each examination, the interval from breeding to diagnosis, and the rate of late embryonic mortality between Day 28 and Day 100 all inform decisions about bull fertility, semen handling, synchronisation protocol efficacy, and nutritional management. A herd with a high rate of late embryonic mortality identified through serial pregnancy diagnosis may benefit from investigation of energy balance, trace mineral status, or infectious causes of pregnancy loss.

The choice of method also affects the interpretation of subsequent examinations. A cow diagnosed pregnant by blood test at Day 28 that returns to estrus at Day 45 has experienced embryonic loss, and the herd record should reflect this outcome. A cow diagnosed pregnant by ultrasound with a confirmed heartbeat at Day 35 has a lower risk of subsequent loss, and the record should distinguish this finding from a blood test result. Maintaining this distinction in the record prevents misinterpretation when pregnancy rates are calculated at the herd level.

Recognized Complications and Failure Modes

Pregnancy diagnosis methods fail in characteriztic patterns, and early recognition of these failures prevents misclassification that disrupts breeding programs.

Early embryonic loss after a positive diagnosis. A cow diagnosed pregnant at Day 28 to 30 may lose the conceptus before Day 60. Circulating pregnancy-associated glycoprotein (PAG) concentrations on Day 28 correlate with the probability of maintaining pregnancy to Day 100, with lower concentrations associated with subsequent embryonic mortality in Nelore beef cows. Clinically, this means a positive blood test or ultrasound finding at Day 30 does not guarantee a term pregnancy. Rechecking high-risk animals, particularly those with a history of embryonic loss or poor body condition, at Day 60 provides a more secure diagnosis.

False negative from sampling too early. Blood-based PAG assays require trophoblast expression to reach detectable thresholds. The first significant rise in serum bPAGs occurs around Day 24 after insemination, and some PAG family members are expressed weakly at Day 25 while others appear earlier. Sampling before Day 28 risks false negatives in normal pregnancies. Transrectal ultrasonography before Day 26 similarly risks missing a viable embryo because the embryonic vesicle may not yet be visible.

Luteal cysts and persistent corpora lutea. A cow with a luteal cyst or a persistent corpus luteum from pyometra or endometritis may be classified as pregnant by palpation or by progesterone assay, since both detect luteal tissue instead of a conceptus. Ultrasound resolves this by direct visualization of the embryo or fetus, and PAG assays avoid it entirely because PAGs are placental products.

Twin reduction and resorption. When twin embryos are present and one is resorbed, a single early positive diagnosis remains correct, but the clinician should be aware that the remaining pregnancy may be normal. The converse error, diagnosing non-pregnancy because only one embryo is seen when two were expected, is uncommon but possible with poor technique.

Mummified fetus. A mummified fetus maintains a corpus luteum and may produce a positive progesterone result, but PAG concentrations decline as placental tissue degenerates. Ultrasound identifies the characteriztic absence of fetal fluid and the amorphous echogenic mass.

Common Errors in Technique and Interpretation

Less experienced clinicians make reproducible errors that are correctable with attention to method.

Palpation errors. The most frequent mistake is attempting diagnosis before the uterus has descended into the pelvic cavity, which occurs around Day 35 in heifers and later in multiparous cows. A second error is confusing the allantoic sac with the rumen or a distended bladder. The discriminating check is to identify the uterine body and trace both horns before assessing fluid fluctuation. Membrane slip, the sensation of fetal membranes sliding between thumb and fingers, is reliable only between approximately Day 35 and Day 60.

Ultrasound errors. Failure to systematically scan both uterine horns leads to missed pregnancies, particularly when the conceptus is in the horn contralateral to the corpus luteum. The gravid horn may be positioned cranially and ventrally, requiring the transducer to be angled forward. Anechoic fluid in the uterine lumen can be mistaken for pregnancy when it represents pyometra or hydrometra. The discriminating check is the presence of a heartbeat, visible from approximately Day 25 to 28, which confirms a live embryo.

Blood test errors. Sample handling errors, including hemolysis and delayed separation, degrade assay performance. The clinician should also recognize that PAG assays detect placental tissue, not fetal viability, so a positive result after embryonic death may persist for days to weeks.

Troubleshooting Guide

Limitations of the Evidence and Areas of Expert Disagreement

The evidence base for pregnancy diagnosis in cattle is uneven. The PAG literature is dominated by studies in Bos taurus dairy breeds and Bos indicus beef breeds, and transferability of thresholds between breeds and production systems is uncertain. The optimal sampling day for blood-based assays remains debated, with recommendations ranging from Day 24 to Day 30 depending on assay sensitivity and the economic cost of false positives versus false negatives.

Expert opinion differs on whether routine early ultrasound at Day 28 to 30 should replace palpation at Day 35 to 45 as the primary diagnostic method. Proponents of early ultrasound cite the ability to resynchronise open cows within days, reducing the interval between services. Clinicians who favour palpation argue that later diagnosis avoids the anxiety of early embryonic loss and requires less equipment. Both positions are defensible, and the choice depends on herd goals, available equipment, and the operator's skill.

There is also disagreement about the clinical utility of quantitative PAG concentrations. Some authors propose using Day 28 PAG levels to predict pregnancy maintenance, but the overlap between cows that maintain and cows that lose pregnancy limits the practical value of a single threshold. The Society for Theriogenology provides professional resources on reproductive management, but does not mandate a single diagnostic protocol.

Referral, Consultation, and Reporting

Most pregnancy diagnoses do not require referral. Specialist consultation is warranted when the diagnosis is ambiguous after repeated examination, when the clinician suspects fetal mummification or maceration, or when the cow has a history of repeated embryonic loss and the cause is not apparent from herd records.

Laboratory involvement is required for PAG assays that are not available as point-of-care tests, and the clinician should confirm the laboratory's validated sampling day and assay characteriztics before interpreting results. Regulatory reporting is rarely relevant to routine pregnancy diagnosis, but the clinician should be aware that some reproductive diseases, including brucellosis, have statutory reporting requirements in many jurisdictions. The World Organization for Animal Health maintains international standards for notifiable reproductive diseases, and the American Veterinary Medical Association provides practice resources on regulatory compliance. The clinician should consult local veterinary authorities when abortion storms or unexplained infertility suggest a notifiable cause.

Frequently Asked Questions

How do I choose a pregnancy diagnosis method when ultrasound is unavailable?

Rectal palpation remains the most practical alternative when ultrasound is not available. Palpation of the amniotic vesicle is possible from approximately Day 30, with membrane slip and cotyledon detection becoming reliable from Day 35 to Day 60. The primary limitation is operator experience, less experienced clinicians should defer definitive diagnosis until Day 45 or later. Blood-based pregnancy-associated glycoprotein testing offers a laboratory alternative that does not require ultrasound or advanced palpation skill. Sample collection is straightforward, and the test can be performed from Day 28 onward. The trade-off is turnaround time and the inability to assess fetal viability or detect twins. For herd-level screening where ultrasound is unavailable, blood testing combined with later palpation for confirmation is a reasonable strategy.

What is the earliest reliable diagnosis for each method, and what are the practical limits?

Transrectal ultrasonography detects the embryonic vesicle as early as Day 25 to Day 27, but experienced operators achieve reliable diagnosis from Day 28 to Day 30. Detection of a heartbeat improves confidence from Day 28 onward. Rectal palpation of the amniotic vesicle is possible from Day 30 in experienced hands, though membrane slip is more consistently detected from Day 35. Blood-based pregnancy-associated glycoprotein assays show the first significant increase around Day 24 after insemination, with commercial tests typically validated from Day 28. The practical limit for all methods is the risk of embryonic mortality, a positive diagnosis before Day 30 does not guarantee pregnancy maintenance to term. Early diagnosis should therefore be paired with a resynchronisation strategy for open cows.

How should I interpret a positive blood test that is not confirmed by ultrasound?

Discordance between blood-based pregnancy-associated glycoprotein results and ultrasound findings most commonly reflects embryonic mortality after the blood sample was collected. Pregnancy-associated glycoproteins have a prolonged half-life, and circulating concentrations may persist for days to weeks after embryonic death. A positive blood test followed by a negative ultrasound therefore does not necessarily indicate a false positive, it may indicate a pregnancy that was lost between sampling and imaging. The reverse pattern, a negative blood test with a positive ultrasound, is less common but can occur with sampling before Day 24 or with assay failure. When discordance arises, repeat the ultrasound in 7 to 10 days. If the ultrasound remains negative, treat the animal as open and proceed with resynchronisation.

What are the cost considerations when choosing a method for a large herd?

Per-animal costs differ substantially by method. Transrectal palpation has the lowest direct cost per animal but requires skilled labor and is time-intensive at herd scale. Ultrasound examination has higher equipment costs but allows earlier diagnosis and provides additional information such as fetal viability, twins, and ovarian status. Blood-based pregnancy-associated glycoprotein testing has a moderate per-sample laboratory cost but enables high-throughput sampling without specialised on-farm equipment. For large herds, the economic decision hinges on the value of early diagnosis. Identifying open cows 10 to 14 days earlier shortens the interval to rebreeding and reduces days open. A herd with a tight calving season may justify higher per-animal costs for earlier diagnosis, whereas a year-round calving herd may prioritize lower-cost methods.

How do I explain a pregnancy diagnosis result to a producer who wants an earlier answer than the method allows?

Clarify that the method chosen determines the earliest reliable answer, and that earlier diagnosis carries a higher risk of embryonic loss after the diagnosis. A producer requesting diagnosis before Day 28 should understand that ultrasound at Day 25 can detect a vesicle but that a proportion of these pregnancies will not survive to Day 60. Frame the discussion around the management decision: if the goal is to resynchronise open cows quickly, early diagnosis with a follow-up check is appropriate. If the goal is to confirm pregnancy for culling or dry-off decisions, a later diagnosis at Day 35 to Day 40 is more reliable. Provide the producer with the sensitivity and specificity figures for the method used and explain that no method eliminates the risk of late embryonic mortality.

What records should I maintain for pregnancy diagnosis, and how do they support herd management?

Record the diagnosis date, method used, gestational age estimate, and the operator for every examination. For ultrasound, note fetal viability, number of fetuses, and any abnormal findings such as pyometra or ovarian pathology. For blood tests, record the sampling date, laboratory, and result. These records allow calculation of conception rates, pregnancy rates, and embryonic mortality rates by service date and bull or semen batch. They also support scheduling of subsequent examinations, dry-off, and calving. Herd-level interpretation of pregnancy diagnosis data identifies seasonal patterns in fertility and flags problems with heat detection or semen handling. Consistent record keeping is a prerequisite for meaningful reproductive performance analysis and for benchmarking against regional or breed averages.

Related Clinical & Scientific Guides

• Diagnostic Approach to Canine Infertility in the Bitch
• Canine Neonatal Resuscitation: Protocol and Monitoring
• Equine Breeding Soundness Examination of the Stallion

References and Further Reading

• Early pregnancy diagnosis in bovines: current status and future directions.. 2013.
• Pregnancy-associated bovine and ovine glycoproteins exhibit spatially and temporally distinct expression patterns during pregnancy.. 2000.
• Strategies for improving fertility in the modern dairy cow.. 2006.
• Estimation of gestational age and assessment of canine fetal maturation using radiology and ultrasonography: a review.. 2008.
• Influence of premature induction of a luteinizing hormone surge with gonadotropin-releasing hormone on ovulation, luteal function, and fertility in cattle.. 2007.
• Use of bovine pregnancy-associated glycoproteins to predict late embryonic mortality in postpartum Nelore beef cows.. 2016.
• Society for Theriogenology Resources. Society for Theriogenology.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.
• American Veterinary Medical Association Practice Resources. American Veterinary Medical Association.

Related Articles

• Equine Pregnancy Diagnosis: Methods and Clinical Application
• Pregnancy Diagnosis in the Bitch: Methods and Interpretation
• Brucellosis in Cattle: Diagnosis and Control Strategies
• Dystocia in Cattle: Causes, Diagnosis, and Management
• Ovine Pregnancy Diagnosis: Transabdominal Ultrasound and Management

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.